Knocking Down Peroxiredoxin 6 Aggravates Cerebral Ischemia-Reperfusion Injury by Enhancing Mitophagy

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Cerebral ischemia-reperfusion injury (IRI) is a major cause of stroke-related brain damage.
• Mitophagy, the selective degradation of mitochondria, plays a critical role in cerebral IRI, with dysregulation potentially leading to neuronal apoptosis.
• Peroxiredoxin 6 (PRDX6), an antioxidant enzyme, is implicated in ischemic stroke, but its precise role in mitophagy during cerebral IRI remains unclear.

Purpose of the Study:

• To investigate the relationship between Peroxiredoxin 6 (PRDX6) and mitophagy in the context of cerebral ischemia-reperfusion injury (IRI).
• To elucidate the underlying molecular mechanisms by which PRDX6 influences mitophagy and neuronal apoptosis following cerebral IRI.

Main Methods:

• Establishment of a middle cerebral artery occlusion (MCAO) model in Sprague-Dawley (SD) rats to induce cerebral ischemia-reperfusion.
• Utilized lentivirus-mediated knockdown of PRDX6 and PINK1 to investigate their specific roles.
• Quantified the expression of mitophagy-related and apoptosis-related proteins.

Main Results:

• Knockdown of PRDX6 significantly aggravated cerebral IRI in the MCAO model.
• PRDX6 knockdown led to increased expression of proteins associated with mitophagy and apoptosis.
• Subsequent knockdown of PINK1 ameliorated the mitophagy and apoptosis induced by PRDX6 knockdown.

Conclusions:

• PRDX6 deficiency exacerbates cerebral IRI by enhancing PINK1/PARKIN pathway-mediated mitophagy.
• The enhanced mitophagy resulting from PRDX6 knockdown contributes to increased neuronal apoptosis.
• PRDX6 plays a protective role in cerebral IRI, potentially through the regulation of mitophagy.